Results 91 to 100 of about 33,834 (215)
Introduction Thrombotic events are more than twice as common in inflammatory bowel disease patients as in the general population. We report an interesting and rare case of portal vein thrombosis as a venous thromboembolic event in the context of ...
Marouf Alhalabi, Duaa Nasri, Widad Aji
doaj +1 more source
ABSTRACT Type 1 Diabetes (T1D) is an autoimmune disorder marked by the immune‐mediated destruction of pancreatic β‐cells, resulting in insulin deficiency and dysregulated glucose control. Current therapies—such as insulin replacement and artificial pancreas systems—manage symptoms but fail to restore endogenous β‐cell function or halt disease ...
Fatemeh Sabet Sarvestani +4 more
wiley +1 more source
It is quite common for portal vein thrombosis to occur in subjects who present predisposing conditions such as cirrhosis, hepatobiliary malignancies, infectious or inflammatory abdominal diseases, or hematologic disorders.
Bogdan Stancu +6 more
doaj +1 more source
Stage of portal vein thrombosis
Qi, Xingshun +3 more
openaire +2 more sources
Although immune checkpoint inhibitors (ICI) have transformed metastatic melanoma treatment, thromboembolic events (TEEs) remain a serious complication. Moreover, existing risk assessment models were developed prior to ICI use and lack clinical validation.
Tim Zell +12 more
wiley +1 more source
Course of Portal Hypertension and Its Prognostic Impact After Liver Transplantation
ABSTRACT Background While portal hypertension (PH) typically resolves after liver transplantation (LT), persistence of PH may affect post‐transplant outcomes. We assessed the evolution of PH after LT and its impact on adverse outcomes. Methods We recorded clinical, laboratory, and imaging parameters of LT recipients between 2016 and 2022 in Vienna and ...
Nina Dominik +20 more
wiley +1 more source
„Bottoms-up“ portal venous recanalization TIPS (PVR-TIPS) utilizing a re-entry catheter
Background Three patients with portal hypertension and gastrointestinal bleeding due to non-cirrhotic portal vein thrombosis were treated with portal venous recanalization transjugular intrahepatic portosystemic shunt (PVR-TIPS) via a trans-splenic ...
Alexander Loizides +3 more
doaj +1 more source
ABSTRACT Introduction The liver is essential for bacterial elimination, preventing intestinal bacteria from entering the systemic circulation, and for producing inflammatory cytokines. Glucocorticoids have been reported to exert heterogeneous effects on bacterial clearance in sepsis.
Katja Hanslin +6 more
wiley +1 more source
Portal Vein Invasion Secondary to Hepatic Hydatid Disease: A Rare Case Report
Background Hydatid cyst disease is a zoonotic parasitic infection caused by Echinococcus species and remains endemic in many regions worldwide, particularly in North Africa and the Mediterranean basin. The liver is the most commonly affected organ due to
Souhaila Akir MD +5 more
doaj +1 more source
Socioeconomic inequalities in receipt of curative‐intent treatment and survival persist among individuals with surveillance‐detected HCC within a universal healthcare system. These findings suggest that surveillance alone is insufficient to ensure equitable outcomes and highlight the need for strategies addressing social determinants across the care ...
Hannes Hagström +6 more
wiley +1 more source

